Skip to main content
. 2022 Dec 15;122(5):384–392. doi: 10.1016/j.jfma.2022.12.002

Table 2.

Sub-group analysis of anti-SARS-CoV2 spike IgG (BAU/mL) titers, geometric means (95%CI), 14 days post 2nd dose, according to vaccine group.

Group 1
ChAdOx1/ChAdOx1 (8w)
(n = 100)
Group 2
ChAdOx1/mRNA-1273 (8w)
(n = 100)
Group 3
ChAdOx1/mRNA-1273 (4w)
(n = 100)
Group 4 mRNA/mRNA-1273 (4w)
(n = 99)
Gender Male 184.8 (131.3–260.2) 1931.0 (1400.2–2663.0) 2921.2 (2243.9–3802.9) 3804.1 (3207.5–4511.6)
Female 196.5 (163.6–235.9) 2436.0 (2099.8–2826.0) 3393.9 (2949.5–3905.3) 3783.4 (3398.4–4211.9)
M: F 20: 80 19: 81 22: 78 40: 59
p-value 0.762 0.177 0.316 0.954
Local erythema Yes 2628.4 (1441.2–4793.4) 3932.6 (1881.9–8217.9) 4409.7 (3111.1–6250.3)
No 194.1 (165.5–227.5) 2306.6 (2006.6–2651.4) 3246.2 (2863.0–3680.7) 3734.9 (3389.9–4115.0)
Y: N 0: 100 8: 92 6: 94 9: 90
p-value 0.601 0.463 0.306
Local swelling Yes 2125.5 (1458.8–3096.7) 3458.2 (2312.5–5171.7) 5368.8 (4124.4–6988.7)
No 194.1 (165.5–227.5) 2369.1 (2048.0–2740.5) 3253.9 (2859.0–3703.3) 3630.4 (3297.8–3996.5)
Y: N 0: 100 15: 85 15: 85 11: 88
p-value 0.568 0.726 0.007∗
Local pain Yes 209.0 (169.4–257.8) 2445.5 (2086.1–2866.8) 3243.2 (2860.2–3677.5) 3795.0 (3445.8–4179.7)
No 172.0 (134.2–220.3) 2033.1 (1576.8–2621.3) 4423.9 (2006.7–9753.0) 3729.7 (2712.3–5128.8)
Y: N 62: 38 74: 26 96: 4 93: 6
p-value 0.239 0.231 0.326 0.935
Fever ≥ 38 °C Yes 155.4 (74.1–325.6) 2711.2 (2104.7–3492.5) 3433.0 (2920.1–4035.8) 3959.4 (3453.1–4540.0)
No 197.3 (167.3–232.9) 2170.7 (1853.5–2542.3) 3110.2 (2565.4–3770.6) 3672.7 (3233.8–4171.2)
Y: N 7: 93 32: 68 55: 45 42: 57
p-value 0.449 0.124 0.429 0.427
Arthralgia/arthritis Yes 667.5 (−) 3148.1 (2380.7–4162.9) 3345.6 (2308.0–4849.6) 4001.0 (2486.6–6437.7)
No 191.7 (163.5–224.6) 2245.8 (1941.4–2597.9) 3275.4 (2869.7–3738.6) 3776.2 (3432.6–4154.3)
Y: N 1: 99 11: 89 12: 88 7: 92
p-value 0.122 0.117 0.912 0.752
Nausea/vomit Yes 113.3 (5.3–2445.4) 2636.6 (1615.6–4302.9) 4278.6 (2614.5–7002.1) 4392.1 (2491.3–7743.2)
No 196.2 (167.0–230.6) 2309.3 (2005.6–2658.9) 3209.1 (2824.3–3646.3) 3762.2 (3421.5–4136.9)
Y: N 2: 98 7: 93 8: 92 5: 94
p-value 0.340 0.618 0.207 0.468
Chills Yes 190.8 (133.1–273.6) 2515.0 (2054.2–3079.2) 3608.9 (3038.3–4286.5) 4074.6 (3559.7–4663.8)
No 194.7 (162.7–233.0) 2160.1 (1805.7–2584.1) 2976.5 (2496.2–3549.1) 3603.7 (3174.8–4090.6)
Y: N 16: 84 50: 50 51: 49 41: 58
p-value 0.928 0.261 0.119 0.194
Headache Yes 207.4 (161.3–266.8) 2237.4 (1860.2–2691.1) 3446.8 (2803.4–3995.5) 3658.8 (3222.6–4153.9)
No 188.6 (153.9–231.2) 2445.5 (2001.6–2987.8) 3214.1 (2701.1–3824.5) 3892.8 (3408.6–4445.7)
Y: N 30: 70 54: 46 53: 47 42: 57
p-value 0.589 0.513 0.745 0.512
Myalgia Yes 211.5 (163.5–273.6) 2339.0 (1970.6–2776.2) 3356.7 (2963.6–3802.0) 3777.6 (3419.9–4172.7)
No 180.4 (147.3–220.8) 2313.5 (1860.4–2877.0) 2629.6 (1434.6–4820.2) 3895.9 (2936.0–5169.8)
Y: N 46: 54 68: 32 91: 9 87: 12
p-value 0.324 0.940 0.259 0.830
Fatigue Yes 197.3 (157.5–247.3) 2410.7 (2025.6–2869.2) 3226.8 (2849.4–3654.1) 3774.2 (3403.1–4185.8)
No 190.1 (151.0–239.5) 2162.3 (1769.6–2642.1) 3919.5 (2103.2–7304.3) 3891.0 (3150.7–4805.4)
Y: N 55: 45 69: 31 92: 8 84: 15
p-value 0.819 0.458 0.370 0.815
Systemic Rash Yes 170.7 (19.3–1508.3) 2188.9 (1414.9–3386.2) 3439.6 (1966.6–6016.0) 3635.7 (2115.9–6247.1)
No 195.4 (168.1–227.1) 2349.0 (2035.6–2710.5) 3270.5 (2879.0–3715.4) 3802.0 (3457.4–4181.0)
Y: N 5: 95 11: 89 8: 92 6: 93
p-value 0.872 0.745 0.826 0.820

IgG: immunoglobulin G, BAU/mL: binding antibody units/mL, CI: confidence interval.